Enfusion, Inc.
NYSE:ENFN
9.05 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 35.604 | 62.545 | 64.365 | 13.938 | 5.898 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 35.604 | 62.545 | 64.365 | 13.938 | 5.898 |
Net Receivables
| 28.069 | 25.855 | 18.223 | 12.18 | 8.975 |
Inventory
| 0 | 6.105 | 0 | 0 | 0 |
Other Current Assets
| 6.179 | 2.303 | 7.09 | 2.793 | 1.292 |
Total Current Assets
| 69.852 | 96.808 | 89.678 | 28.911 | 16.165 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 32.618 | 22.491 | 13.051 | 8.784 | 6.008 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 6.502 | 4.484 | 3.356 | 1.404 | 1.024 |
Total Non-Current Assets
| 39.12 | 26.975 | 16.407 | 10.188 | 7.032 |
Total Assets
| 108.972 | 123.783 | 106.085 | 39.099 | 23.197 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 2.212 | 1.685 | 2.528 | 0.484 | 0.443 |
Short Term Debt
| 4.256 | 4.03 | 0 | 2.5 | 0.3 |
Tax Payables
| 2.398 | 0.285 | 1.216 | 0.414 | 0.291 |
Deferred Revenue
| 2.398 | 0 | 0 | 7.4 | 7.158 |
Other Current Liabilities
| 11.443 | 11.665 | 5.578 | 0.266 | 0.169 |
Total Current Liabilities
| 20.309 | 17.38 | 8.106 | 10.65 | 8.07 |
Non-Current Liabilities: | |||||
Long Term Debt
| 11.181 | 2.959 | 0 | 96.063 | 27.357 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 0 | 0.538 | 165.945 | 105.649 |
Total Non-Current Liabilities
| 11.181 | 2.959 | 0.538 | 262.008 | 133.006 |
Total Liabilities
| 31.49 | 20.339 | 8.644 | 272.658 | 141.076 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 106.085 | 165.515 | 105.073 |
Common Stock
| 0.127 | 0.114 | 0.113 | 0 | 0 |
Retained Earnings
| -172.932 | -178.863 | -0.328 | 67.832 | 12.71 |
Accumulated Other Comprehensive Income/Loss
| -0.406 | -0.504 | -171.209 | -0.212 | -0.096 |
Other Total Stockholders Equity
| 226.877 | 244.26 | 120.632 | -233.347 | -117.783 |
Total Shareholders Equity
| 53.666 | 65.007 | 55.293 | -233.559 | -117.879 |
Total Equity
| 77.482 | 103.444 | 97.441 | -233.559 | -117.879 |
Total Liabilities & Shareholders Equity
| 108.972 | 123.783 | 106.085 | 39.099 | 23.197 |